We are live on
!
Find out more
Bank Julius Baer & Co Portfolio holdings
AUM
$33.2B
1-Year Est. Return
25.01%
This Fund
S&P 500
This Quarter
Est. Return
+11.03%
1 Year Est. Return
+25.01%
3 Year Est. Return
+91.4%
5 Year Est. Return
+116.23%
10 Year Est. Return
–
AUM
$12.2B
AUM Growth
+$1.94B
(+19%)
Cap. Flow
+$966M
Cap. Flow
% of AUM
7.93%
Top 10 Holdings %
Top 10 Hldgs %
35.71%
Holding
880
New
146
Increased
371
Reduced
267
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$249M |
| 2 |
PayPal
PYPL
|
+$72.8M |
| 3 |
MarketAxess Holdings
MKTX
|
+$69.9M |
| 4 |
Idexx Laboratories
IDXX
|
+$69.2M |
| 5 |
NVIDIA
NVDA
|
+$67.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$257M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$110M |
| 3 |
VMW
VMware, Inc
VMW
|
+$83.9M |
| 4 |
TJX Companies
TJX
|
+$72.9M |
| 5 |
CME Group
CME
|
+$62.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 13.02% |
| 4 | Communication Services | 9.27% |
| 5 | Consumer Discretionary | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
St. Joe Company
JOE
$3.79B
| $30K | ﹤0.01% |
+707
| New | +$22.5K |
|
|
FIRY
727
Firy Inc
FIRY
$163M
| $30K | ﹤0.01% |
+75
| New | +$22.3K |
|
728
Toronto Dominion Bank
TD
$201B
| $30K | ﹤0.01% |
532
+4
| +0.8% | +$203 |
|
|
MYOV
729
DELISTED
Myovant Sciences Ltd.
MYOV
| $30K | ﹤0.01% |
+1,086
| New | +$21.1K |
|
|
FSR
730
DELISTED
Fisker Inc.
FSR
| $29K | ﹤0.01% |
1,980
-23
| -1% | -$338 |
|
731
Advance Auto Parts
AAP
$3.36B
| $27K | ﹤0.01% |
+171
| New | +$26.4K |
|
732
Baker Hughes
BKR
$62.5B
| $27K | ﹤0.01% |
1,295
+10
| +0.8% | +$176 |
|
733
ImmunityBio
IBRX
$7.99B
| $27K | ﹤0.01% |
+2,026
| New | +$19.5K |
|
734
Lucid Motors
LCID
$2.58B
| $25K | ﹤0.01% |
+250
| New | +$24.5K |
|
735
Tilray
TLRY
$612M
| $25K | ﹤0.01% |
+303
| New | +$22.1K |
|
736
TotalEnergies
TTE
$193B
| $25K | ﹤0.01% |
597
-3
| -0.5% | -$116 |
|
|
CLVS
737
DELISTED
Clovis Oncology, Inc.
CLVS
| $24K | ﹤0.01% |
5,000
-5,000
| -50% | -$25.3K |
|
738
Arbutus Biopharma
ABUS
$909M
| $23K | ﹤0.01% |
6,479
+4,979
| +332% | +$17.4K |
|
|
DFS
739
DELISTED
Discover Financial Services
DFS
| $22K | ﹤0.01% |
243
+38
| +19% | +$2.83K |
|
740
Ford
F
$55B
| $22K | ﹤0.01% |
2,503
-1
| -0% | -$8 |
|
741
Jefferies Financial Group
JEF
$12.9B
| $22K | ﹤0.01% |
935
-1
| -0.1% | -$21 |
|
|
SYBX
742
DELISTED
Synlogic
SYBX
| $22K | ﹤0.01% |
679
-654
| -49% | -$20.9K |
|
743
Plains GP Holdings
PAGP
$4.96B
| $21K | ﹤0.01% |
+2,485
| New | +$19.3K |
|
744
FuboTV Inc
FUBO
$262M
| $20K | ﹤0.01% |
+60
| New | +$16.4K |
|
745
Pan American Silver
PAAS
$21.2B
| $20K | ﹤0.01% |
580
-2,699
| -82% | -$87.1K |
|
746
Royalty Pharma
RPRX
$25.6B
| $20K | ﹤0.01% |
400
+10
| +3% | +$424 |
|
747
Yum! Brands
YUM
$40.2B
| $20K | ﹤0.01% |
184
+4
| +2% | +$408 |
|
|
ICPT
748
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $20K | ﹤0.01% |
810
-5
| -0.6% | -$166 |
|
|
BCLI
749
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $19K | ﹤0.01% |
280
-131
| -32% | -$17.8K |
|
750
Essex Property Trust
ESS
$18.2B
| $19K | ﹤0.01% |
80
+2
| +3% | +$461 |
|
Similar funds
PPF
GAM
VIA
Bank Julius Baer & Co's Q4 2020 Portfolio in Review
As of Q4 2020, Bank Julius Baer & Co held 880 positions worth $12.2B, up 19% from $10.2B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Bank Julius Baer & Co deployed $966M of net new capital in Q4 2020, opening 146 new positions and adding to 371 existing holdings. Its largest new stake was Deckers Outdoor: 641,742 shares worth $30.7M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $257M trimmed.
- Bank Julius Baer & Co's largest Q4 2020 buy was Deckers Outdoor: 641,742 shares worth $30.7M.
- Bank Julius Baer & Co added most to Thermo Fisher Scientific in Q4 2020, an estimated $249M increase.
- Bank Julius Baer & Co's biggest Q4 2020 reduction was Johnson & Johnson, cutting an estimated $257M.
- Bank Julius Baer & Co fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2020, selling an estimated $110M.
- Bank Julius Baer & Co's ten largest holdings make up 36% of its $12.2B portfolio in Q4 2020.
- Bank Julius Baer & Co opened 146 new positions and closed 78 in Q4 2020.
- Bank Julius Baer & Co's portfolio value rose 19% quarter-over-quarter to $12.2B.
Based on Bank Julius Baer & Co's 13F filing for Q4 2020, filed 12 Feb 2021.